Choose content
Displaying 37 to 48 of 159 results
Generic justification
Lu oxodotreotide for the treatment of metastatic or inoperable gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
FoilsitheGeneric justification
Methods for Generic Justification of New Practices in Ionising Radiation
FoilsitheGeneric justification
A slot-scanning, biplanar, digital X-ray imaging system for the evaluation and monitoring of orthopaedic conditions
FoilsitheAssessment
Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)
FoilsitheAssessment
Overview of multiplex antigen near-patient tests for acute respiratory infections
FoilsitheAssessment
Health technology assessment of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme
FoilsitheGeneric justification
Ultra-hypofractionated adjuvant radiotherapy for breast cancer: evidence synthesis to support a generic justification decision
FoilsitheGeneric justification
¹⁸F-prostate-specific membrane antigen (PSMA) PET/CT imaging for the staging of high-risk or recurrent prostate cancer: Evidence synthesis to support a generic justification decision
FoilsitheAssessment
Herpes Zoster (shingles) vaccination: Protocol for a health technology assessment
FoilsitheCOVID-19 report
Factors associated with outbreaks of SARS-CoV-2 in nursing homes
UpdatedCOVID-19 report
Rolling summary of Omicron evidence, epidemiology and guidance
UpdatedCOVID-19 report
Descriptive analysis of COVID-19 epidemiological indicators and associated contextual factors in European countries
Foilsithe